Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults and Pediatrics

NCT06013423 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT06013423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06013423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Cord Blood Transplantation for the Treatment of High-Risk Hematologic Malignancies in Adults and Pediatrics
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Phase 2
Overall status
Recruiting
Start date
July 23, 2024
Completion date
October 31, 2032
Enrollment
54 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute leukemia of ambiguous lineage, acute lymphoblastic leukemia, acute myeloid leukemia, blastic plasmacytoid dendritic cell neoplasm, chronic myeloid leukemia, bcr-abl1 positive, hematopoietic and lymphatic system neoplasm, mixed phenotype acute leukemia, myelodysplastic syndrome, myeloproliferative neoplasm, non-hodgkin lymphoma